ropinirole + dextromethorphan

This drug is a **combination of ropinirole and dextromethorphan**. - **Ropinirole** is a non-ergoline dopamine agonist primarily used to treat Parkinson’s disease and restless legs syndrome. It selectively binds to D2 dopamine receptors in the central nervous system, modulating dopaminergic activity, which improves motor and sleep symptoms in these disorders[2][8]. - **Dextromethorphan** is an NMDA receptor antagonist and sigma-1 receptor agonist, mainly used as a cough suppressant. It is also under investigation for several neurologic and psychiatric indications due to its effects on glutamatergic and sigma-1 receptor systems[1][7]. - The combination of these two agents may be investigated for neuropsychiatric or movement disorder indications, but no branded formulation or clinical precedence for this specific dual combination is reported in major databases as of the present date.